Alpha Tau Medical to Present at J.P. Morgan Healthcare Conference
Ticker: DRTSW · Form: 6-K · Filed: Dec 18, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Dec 18, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference-presentation, healthcare
TL;DR
Alpha Tau Medical presenting at JPM Healthcare Conference in Jan 2026 - good for visibility.
AI Summary
Alpha Tau Medical Ltd. announced on December 18, 2025, that it will present at the J.P. Morgan 2026 Healthcare Conference. The company, headquartered in Jerusalem, Israel, is involved in surgical and medical instruments and apparatus.
Why It Matters
Presentation at a major healthcare conference like J.P. Morgan's can increase visibility and attract potential investors or partners for Alpha Tau Medical.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference, with no new financial or operational information that would significantly alter risk.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- J.P. Morgan 2026 Healthcare Conference (event) — Presentation venue
- December 18, 2025 (date) — Announcement date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report that Alpha Tau Medical Ltd. issued a press release on December 18, 2025, announcing their participation in the J.P. Morgan 2026 Healthcare Conference.
When was the press release issued?
The press release was issued on December 18, 2025.
What conference will Alpha Tau Medical Ltd. be presenting at?
Alpha Tau Medical Ltd. will be presenting at the J.P. Morgan 2026 Healthcare Conference.
Where is Alpha Tau Medical Ltd. headquartered?
Alpha Tau Medical Ltd. is headquartered in Jerusalem, Israel.
Is the information in this report considered 'filed' for Section 18 purposes?
No, the information in this Report on Form 6-K, including Exhibit 99.1, is being furnished and shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
Filing Stats: 299 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2025-12-18 09:02:01
Filing Documents
- ea0270145-6k_alpha.htm (6-K) — 15KB
- ea027014501ex99-1_alpha.htm (EX-99.1) — 7KB
- 0001213900-25-123068.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: December 18, 2025 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3